News: Thomson Reuters Corp (TRI.TO)

TRI.TO on Toronto Stock Exchange

39.51CAD
11 Jul 2014
Price Change (% chg)

$0.16 (+0.41%)
Prev Close
$39.35
Open
$39.49
Day's High
$39.53
Day's Low
$39.26
Volume
355,714
Avg. Vol
598,281
52-wk High
$42.10
52-wk Low
$34.52

Search Stocks
Select another date:

Wed, Jun 18 2014

UPDATE 1-Financial service provider Markit's IPO raises $1.28 bln

June 18 - Markit Ltd said it priced its initial public offering at $24 per share, valuing the financial information service provider at about $4.3 billion.

Financial service provider Markit's IPO raises $1.2 billion: WSJ

- Markit Ltd priced its initial public offering at $24 per share, valuing the financial information service provider at about $4.3 billion, the Wall Street Journal reported, citing sources.

Medtronic's Covidien deal raises bar for rivals to merge

- Medtronic Inc's $43 billion deal for Dublin-based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday. | Video

Medtronic to buy Covidien for $42.9 billion, rebase in Ireland

- U.S. medical device maker Medtronic Inc said on Sunday it had agreed to buy Covidien Plc for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.

Medtronic nears $45 billion-plus deal for Covidien: sources

- U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

UPDATE 1-Markit IPO may value company at about $4.47 bln

June 3 - Financial information service provider Markit Ltd said it expected its IPO to be priced at $23-$25 per share, which could value the company at up to $4.47 billion.

Markit IPO may value company at about $4.47 bln

June 3 - Financial information service provider Markit Ltd said it expected its IPO to be priced at $23-$25 per share, which could value the company at up to $4.47 billion.

Republican senator spars with veterans groups on care delays

WASHINGTON - The top Republican on the Senate Veterans Affairs Committee fired back at some leading veterans groups on Tuesday after they accused him of a "mean spirited" attempt to politicize the scandal over delays in medical care at VA hospitals and clinics.

Valeant says improved bid for Allergan won't be all-cash

LAVAL, QUEBEC - Canada's Valeant Pharmaceuticals International said on Tuesday it will not make an all-cash bid for drugmaker Allergan Inc as many had expected last week when the company said it would improve its cash and stock offer for the Botox maker.

Valeant to sweeten Allergan bid, Ackman turns up heat

- Valeant Pharmaceuticals International Inc said on Tuesday it will sweeten its unsolicited $47 billion offer for drugmaker Allergan Inc , and activist shareholder Pershing Square Capital Management said it would ask for a non-binding vote to pressure Allergan to the negotiating table.

Select another date:
Search Stocks